Literature DB >> 770031

Octopamine plasma levels and hepatic encephalopathy: a re-appraisal of the problem.

F Rossi-Fanelli, C Cangiano, A Attili, M Angelico, A Cascino, L Capocaccia, R Strom, C Crifó.   

Abstract

An investigation on the blood levels of octopamine was carried out on 70 adult individuals. There was a statistically significant correlation between the levels of octopamine and hepatic encephalopathy. Normal subjects had values below 1 ng/ml, while patients with grade 3 or grade 4 encephalopathy constantly showed values above 3.2 ng/ml. In these two groups the distribution was fairly homogeneous. Through the differences between cirrhotics without neurologic involvement and those with grade 1 or 2 hepatic encephalopathy displayed statistical significance, distribution of values in these groups was rather non-homogeneous. Octopamine levels paralleled variations in mental state in 3 out 4 cases. No difference was found between venous and arterial values. The reaction of transmethylation used in the assay of octopamine was constantly found to be inhibited by the presence of plasma. This inhibition is probably due to the presence of one or more beta-hydroxyphenylethanolamines other than octopamine.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 770031     DOI: 10.1016/0009-8981(76)90333-8

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

1.  Plasma catecholamines in hepatic coma and liver cirrhosis: role of octopamine.

Authors:  H Hörtnagl; H Lochs; G Kleinberger; J M Hackl; A F Hammerle; H Binder; F Wewalka
Journal:  Klin Wochenschr       Date:  1981-10-15

2.  Plasma amino acids imbalance in patients with liver disease.

Authors:  A Cascino; C Cangiano; V Calcaterra; F Rossi-Fanelli; L Capocaccia
Journal:  Am J Dig Dis       Date:  1978-07

3.  Alterations in plasma and CSF amino acids, amines and metabolites in hepatic coma.

Authors:  A R Smith; F Rossi-Fanelli; V Ziparo; J H James; B A Perelle; J E Fischer
Journal:  Ann Surg       Date:  1978-03       Impact factor: 12.969

4.  Hyperprolactinemia in portal systemic encephalopathy.

Authors:  C J McClain; J P Kromhout; M K Elson; D H Van Thiel
Journal:  Dig Dis Sci       Date:  1981-04       Impact factor: 3.199

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.